WTFG
AZN icon

Wood Tarver Financial Group’s AstraZeneca AZN Stock Holding History

Wood Tarver Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$2K – 194
2025
Q2 		$2K Hold
16
– – ﹤0.01% 509
2025
Q1 		$2.35K Hold
16
– – ﹤0.01% 513
2024
Q4 		$2K Buy
+16
New +$2.24K ﹤0.01% 495

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wood Tarver Financial Group's AZN Position: Q3 2025 in Review

Wood Tarver Financial Group sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 16 shares — an estimated $2K sold.

Wood Tarver Financial Group first reported a position in AZN in Q4 2024 and held it in 3 quarters. The position peaked at $2.35K in Q1 2025. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Wood Tarver Financial Group reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • Wood Tarver Financial Group sold 16 AstraZeneca shares in Q3 2025, an estimated $2K.
  • Wood Tarver Financial Group first reported a position in AstraZeneca in Q4 2024 and held it in 3 quarters.
  • Wood Tarver Financial Group's AstraZeneca position peaked at $2.35K in Q1 2025.
  • 1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Wood Tarver Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.